Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 9
1968 16
1969 20
1970 25
1971 31
1972 32
1973 44
1974 47
1975 46
1976 31
1977 27
1978 24
1979 32
1980 32
1981 28
1982 26
1983 16
1984 35
1985 41
1986 34
1987 42
1988 26
1989 41
1990 34
1991 53
1992 73
1993 74
1994 63
1995 111
1996 122
1997 120
1998 144
1999 141
2000 140
2001 133
2002 107
2003 138
2004 105
2005 103
2006 111
2007 111
2008 123
2009 108
2010 109
2011 137
2012 123
2013 135
2014 143
2015 128
2016 128
2017 152
2018 151
2019 155
2020 137
2021 143
2022 144
2023 122
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

4,420 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxyurea therapy for sickle cell anemia.
McGann PT, Ware RE. McGann PT, et al. Expert Opin Drug Saf. 2015;14(11):1749-58. doi: 10.1517/14740338.2015.1088827. Epub 2015 Sep 14. Expert Opin Drug Saf. 2015. PMID: 26366626 Free PMC article. Review.
Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations.
Marchetti M, Vannucchi AM, Griesshammer M, Harrison C, Koschmieder S, Gisslinger H, Álvarez-Larrán A, De Stefano V, Guglielmelli P, Palandri F, Passamonti F, Barosi G, Silver RT, Hehlmann R, Kiladjian JJ, Barbui T. Marchetti M, et al. Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1. Lancet Haematol. 2022. PMID: 35358444 Review.
Hydroxyurea-induced lunular hyperpigmentation.
Divyashree K, Gupta R, Chandana VS, Pannu AK. Divyashree K, et al. BMJ Case Rep. 2022 Mar 15;15(3):e249123. doi: 10.1136/bcr-2022-249123. BMJ Case Rep. 2022. PMID: 35292553 Free PMC article. No abstract available.
Hydroxyurea therapy.
Boyd AS, Neldner KH. Boyd AS, et al. J Am Acad Dermatol. 1991 Sep;25(3):518-24. doi: 10.1016/0190-9622(91)70233-r. J Am Acad Dermatol. 1991. PMID: 1918491 Review.
Hydroxyurea: an overview.
Stevens MR. Stevens MR. J Biol Regul Homeost Agents. 1999 Jul-Sep;13(3):172-5. J Biol Regul Homeost Agents. 1999. PMID: 10560751 Review.
Hydroxyurea: coming to conclusions on safety.
Rees DC. Rees DC. Blood. 2021 Feb 11;137(6):728-729. doi: 10.1182/blood.2020008803. Blood. 2021. PMID: 33570610 Free article. No abstract available.
Hydroxyurea-induced Tooth Discoloration.
Okuyucu M, Atay MH. Okuyucu M, et al. Turk J Haematol. 2020 Feb 20;37(1):74-75. doi: 10.4274/tjh.galenos.2019.2019.0275. Epub 2019 Nov 12. Turk J Haematol. 2020. PMID: 31711282 Free PMC article. No abstract available.
Hydroxyurea-induced dermatomyositis-like eruption.
Senet P, Aractingi S, Porneuf M, Perrin P, Duterque M. Senet P, et al. Br J Dermatol. 1995 Sep;133(3):455-9. doi: 10.1111/j.1365-2133.1995.tb02677.x. Br J Dermatol. 1995. PMID: 8547004 Review.
4,420 results